SANUWAVE Health Inc at MicroCap Rodeo -- Windy City Roundup Transcript
Okay, good morning. I'm Morgan Frank. I'm the Chairman of SANUWAVE wound care. We are a commercial stage medical device company in the -- I know I don't have presentation issue here. In the $45 billion US wound care space. We sell products both in the United States and abroad. We have two FDA approved products. This market is currently undergoing a very significant change. And that change is the transition to evidence-based medicine.
So what does that change look like? This is a huge market. [Their reasons kick ahead multiples.] So this is a huge market. It's over $45 billion in the US alone. And diabetic foot ulcers alone, our market bigger than breast cancer. This has created a few -- the growth industry with the sort of drivers you'd expect. You've got an increase in -- in the aging population, you've got more diabetes, you've got more obesity.
These are all of the things that drive a need for wound care. But the markets are large, and this turns it into something of a pain point, particularly for the payers. And this is what's driving
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
